摘要
目的 观察拉米夫定联合转移因子胶囊治疗慢性乙型肝炎的疗效。方法 65例慢性乙型肝炎病人随机分成联合治疗组 (3 3例 )和拉米夫定组 (3 2例 )。联合治疗组应用拉米夫定 ,10 0mg/d ,口服 ,疗程 1年 ;转移因子胶囊 6mg ,口服 ,每天 2次 ,疗程 3个月。拉米夫定组应用拉米夫定 ,10 0mg/d ,口服 ,疗程 1年。结果 在治疗 3、6、12个月时 ,HBeAg转阴率和抗 -HBe转阳率联合治疗组明显高于拉米夫定组 (P <0 0 5 )。结论 拉米夫定联合转移因子胶囊治疗慢性乙型肝炎可提高疗效。
Objective To observe the efficacy of treating chronic hepatitis B with lamivudine and transfer factor capsules.Methods 65 patients with chronic hepatitis B were randomly diveded into combining treatment group(33 cases)and lamivudine group(32 cases).The combining treatment group was treated with lamivudine,100mg/d,orally,the therapeutical course was 1 year;transfer factor capsules,6mg,orally,two times each day,the therapeutical course was 3 months.The lamivudine group was treated with lamivudine,100mg/d,orally,the therapeutical course was 1 year.Result At3,6,12months of treatment,The HBeAg negative rate and anti-HBe positive rate in combining group were significantly higher than in lamivudine group.Conclusion Treating chronic hepatitis B with lamivu dine and tranfer factor capsules had a coordinated effect.
出处
《中国厂矿医学》
2004年第1期8-9,共2页
Chinese Medicine of Factory and Mine
